Continuous glucose monitor (CGM)
DEKontinuierliches Glukosemessgerät (CGM)
Reviewed by Maurice Lichtenberg
A continuous glucose monitor (CGM) is a wearable sensor, typically inserted into subcutaneous tissue, that measures interstitial glucose every few minutes, typically about 7 to 14 days for transcutaneous sensors (system-dependent), and up to a year for implantable devices such as Eversense 365. It generates trend data on fasting, postprandial, and nocturnal glucose, time-in-range, and glycemic variability. CGMs are increasingly used in non-diabetic adults to personalize nutrition and inform longevity-oriented lifestyle adjustments.
Sources
- Uhl S, Choure A, Rouse B, Loblack A, Reaven P. (2024). Effectiveness of Continuous Glucose Monitoring on Metrics of Glycemic Control in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis. *Journal of Clinical Endocrinology & Metabolism*doi:10.1210/clinem/dgad652
- Seidu S, Kunutsor SK, Ajjan RA, Choudhary P. (2024). Efficacy and Safety of Continuous Glucose Monitoring and Intermittently Scanned Continuous Glucose Monitoring in Patients With Type 2 Diabetes. *Diabetes Care*doi:10.2337/dc23-1520
